The pharmaceutical landscape in this country is increasingly characterized by a pattern toward market concentration, with a handful of prominent companies wielding significant control. These sector giants, often bolstered by extensive distribution networks and robust brand recognition, present a difficult picture for competition and affordable heal

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces increasing concerns about monopolies. A few dominant players control a significant percentage of the market, potentially restricting competition and driving up prices for consumers. This situation raises doubts about the long-term impact on patient access